QQ客服 官方微博 反馈留言

	CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC
	Liu, Youyi; Liu, Lijuan; Zhou, Yan; Zhou, Ping; Yan, Qiujin; Chen, Xiaobei; Ding, Shuang; Zhu, Fan
刊名	CLINICAL CANCER RESEARCH
	2019
卷号	25期号:13
ISSN号	1078-0432
DOI	10.1158/1078-0432.CCR-18-3510
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4233481
专题	武汉大学
推荐引用方式 GB/T 7714	Liu, Youyi,Liu, Lijuan,Zhou, Yan,et al. CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC[J]. CLINICAL CANCER RESEARCH,2019,25(13).
APA	Liu, Youyi.,Liu, Lijuan.,Zhou, Yan.,Zhou, Ping.,Yan, Qiujin.,...&Zhu, Fan.(2019).CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC.CLINICAL CANCER RESEARCH,25(13).
MLA	Liu, Youyi,et al."CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC".CLINICAL CANCER RESEARCH 25.13(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。